Cargando…
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a new psychoactive substance with strong hallucinogenic properties. Our previous data reported increased release of dopamine, serotonin, and glutamate after acute injections and a tolerance development in the neurotransmitters rel...
Autores principales: | Herian, Monika, Wojtas, Adam, Maćkowiak, Marzena, Wawrzczak-Bargiela, Agnieszka, Solarz, Anna, Bysiek, Agnieszka, Madej, Katarzyna, Gołembiowska, Krystyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861095/ https://www.ncbi.nlm.nih.gov/pubmed/35190675 http://dx.doi.org/10.1038/s41598-022-07069-8 |
Ejemplares similares
-
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2021) -
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
por: Wojtas, Adam, et al.
Publicado: (2020) -
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission
por: Herian, Monika, et al.
Publicado: (2020) -
Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats
por: Herian, Monika, et al.
Publicado: (2019) -
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
por: Wojtas, Adam, et al.
Publicado: (2022)